233 results
Responsible body
PRAC Remove PRAC filter
-
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 11-14 January 2016
PRAC, Last updated: 15/01/2016pharmacovigilance processes (e.g. spontaneous reporting of … engagement of key stakeholders (e.g. patients, healthcare professionals … measurable health outcomes (e.g. reduction of harm from adverse … -
List item
News: Pharmacovigilance Risk Assessment Committee (PRAC) invites stakeholders' feedback in review of Diane 35 and its generics
PRAC, Last updated: 12/02/2013inviting all stakeholders, e.g., healthcare professionals … -
List item
News: Benefits of ifosfamide solutions continue to outweigh risks EMA’s safety committee (PRAC) has concluded that the benefits of ifosfamide solutions for infusion
PRAC, Last updated: 12/03/2021generic formulation (IFOSFAMIDE EG®). J Clin Pharm Ther. 2019;44:372–380 … -
List item
Press release: Review of oral methadone medicines containing povidone started
PRAC, Last updated: 11/04/2014invites all stakeholders (e.g. healthcare professionals … invites all stakeholders (e.g. healthcare professionals … -
List item
News: Comirnaty and Spikevax: possible link to very rare cases of myocarditis and pericarditis
PRAC, Last updated: 09/07/2021and/or consult specialists (e.g. cardiologists) to diagnose … and/or consult specialists (e.g. cardiologists) to diagnose … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 23-26 October 2017
PRAC, Last updated: 27/10/2017invites all stakeholders (e.g. healthcare professionals … http://www.efsa.europa.eu) EGA European Generic Medicines … Medicines Association (http://www.egagenerics.com) EMA European Medicines … -
List item
Press release: Listening to the public's views on the safety of medicines
PRAC, Last updated: 15/04/2016stage of a safety review, e.g. through stakeholder submissions … stage of a safety review, e.g. through stakeholder submissions … -
List item
Press release: Updated recommendations to minimise the risk of the rare brain infection PML with Tysabri
PRAC, Last updated: 12/02/2016more frequent MRI scans (e.g. every 3 to 6 months) should … more frequent MRI scans (e.g. every 3 to 6 months) should … -
List item
Press release: PRAC recommends further measures to minimise risk of blood vessel blockage with Iclusig
PRAC, Last updated: 10/10/2014included additional warnings (e.g. against use in patients … included additional warnings (e.g. against use in patients … -
List item
News: European Medicines Agency launches public consultation on rules of procedures for public hearings
PRAC, Last updated: 24/07/2014stage of a safety review, e.g. through stakeholder submissions … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28 September - 1 October 2020
PRAC, Last updated: 02/10/2020by other factors as well, e.g. diabetes; importantly, COVID-19 … http://www.efsa.europa.eu) EGA European Generic Medicines … Medicines Association (http://www.egagenerics.com) EMA European Medicines … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 23-26 November 2020
PRAC, Last updated: 27/11/2020experience mental health problems (e.g. irrational thoughts, anxiety … http://www.efsa.europa.eu) EGA European Generic Medicines … Medicines Association (http://www.egagenerics.com) EMA European Medicines … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 March 2021
PRAC, Last updated: 12/03/2021generic formulation (IFOSFAMIDE EG®). J Clin Pharm Ther. 2019;44:372–380 … -
List item
News: COVID-19 Vaccine Janssen: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets
PRAC, Last updated: 20/04/2021and/or consult specialists (e.g., haematologists, specialists … and/or consult specialists (e.g., haematologists, specialists … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10 - 12 May 2023
PRAC, Last updated: 22/05/2023non-bacterial infections, e.g. non-bacterial (chronic … -
List item
Press release: Use of multiple sclerosis medicine Lemtrada restricted while EMA review is ongoing
PRAC, Last updated: 12/04/2019suggestive of hepatic dysfunction (e.g. unexplained nausea, vomiting … -
List item
News: Review of pholcodine medicines started
PRAC, Last updated: 02/09/2022invites all stakeholders (e.g. healthcare professionals … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 5 August 2021
PRAC, Last updated: 06/08/2021unexpected vaginal bleeding (e.g. in postmenopausal women … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 5-8 July 2021
PRAC, Last updated: 09/07/2021and/or consult specialists (e.g. cardiologists) to diagnose … -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 26-29 September 2022
European Medicines Agency, Amsterdam, the Netherlands, from 26/09/2022 to 29/09/2022, Last updated: 04/07/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 24-27 October 2016
European Medicines Agency, London, UK, from 24/10/2016 to 27/10/2016, Last updated: 13/03/2014 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 26-29 September 2022
PRAC, Last updated: 30/09/2022 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 25-28 September 2023 (updated)
PRAC, Last updated: 29/09/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 25-28 September 2023 (updated)
European Medicines Agency, Amsterdam, the Netherlands, from 25/09/2023 to 28/09/2023, Last updated: 25/09/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 3-6 July 2023 (updated)
European Medicines Agency, Amsterdam, the Netherlands, from 03/07/2023 to 06/07/2023, Last updated: 21/09/2023